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The vascularity of cutaneous melanoma: a quantitative histological study
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Summary The vascularity of 107 primary cutaneous melanomas has been characterized by morphometric
histological analysis. The lesions selected for study were of thickness 0.85-1.25 mm and the aim was to
evaluate the prognostic significance of tumour vascularity. Two groups of patients were identified; 86 with no
evidence of recurrence after a minimum follow-up period of 5 years and 21 with locoregional recurrence
and/or metastasis. The lectin Ulex europaeus type I was used for endothelial cell staining of tissue sections and
morphometric analysis was performed to derive the vascular length, surface and volume density from
independent measurements of tumour, adjacent dermis and the junctional zone between tumour and underly-
ing tissue. A wide range of values was obtained for each parameter with increased vascularity always found at
the tumour base compared with the tumour as a whole. In relation to the adjacent normal dermis, vascularity
was generally found to be higher at the tumour base but either higher or lower in the tumour overall. Tumour
recurrence could not be predicted by any of the derived vascular parameters either independently or together
with other histological and clinical features.
This study suggests that tumour vascularity is of no prognostic significance in melanoma of the above
thickness range. The highly variable extent of tumour vascularity was not correlated with other clinical or
histological parameters, but may have implications for the delivery of pharmaceutical agents used for
diagnosis or therapy.
Cutaneous malignant melanoma is an uncommon tumour
though the incidence in several countries has increased sub-
stantially in recent years. in the UK about 3,000 new cases
are diagnosed annually. Breslow (1970) first demonstrated
the prognostic significance of the histological thickness of the
primary lesion, and this remains the best single predictive
parameter. However it has been subsequently shown that the
relationship between tumour thickness and prognosis is non-
linear, and it has proved more difficult to predict the likeli-
hood of metastasis in patients with lesions of intermediate
(0.76-3.99mm) thickness (Day et al., 1982a,b).
With the aim of improving the accuracy of prognosis,
attention has been given to the significance of the network of
tumour associated blood vessels. In a preliminary study,
Srivastava et al. (1986) demonstrated that the degree of
tumour vascularity assessed by histology was related to lesion
thickness. The increased vascularity of thicker lesions was
also evidenced by an Ultrasound Doppler signal measured in
the vicinity of the tumour prior to surgery. The prognostic
significance of tumour vascularity was subsequently demon-
strated in a small series of intermediate-thickness lesions
(Srivastava et al., 1988, 1989), patients developing metastases
being generally found to have the more vascular primary
tumours.
When studied histologically three measurable morpho-
logical characteristics of blood vessels may be identified: their
number, boundary length and luminal area. These para-
meters may be used to estimate vessel length (Lu), surface (S,)
and volume (Vp) density per unit reference volume of tissue.
Morphometric histological studies of tumour vasculature
have generally involved the estimation of(V,) using the point
counting method for area fraction measurement first des-
cribed by Chalkley (1943). An inherent problem with this
approach in excised tissue is the vascular collapse that occurs
during the preparation of tissue sections, leading to the
underestimation of true vascular volume density. A more
stable feature of vascular morphology is the vessel circum-
ference, which may be measured independently and used to
derive estimates of S,. The surface area of the vascular bed
has an important influence upon the exchange of solutes (and
cells) between the circulation and the tumour parenchyma. A
suitable morphometric method for S, estimation has been
described (Weibel, 1963), but the application to general
studies of the microcirculation has not been reported to date.
A further advantage of this method is that it does not require
the independent estimation of vessel diameter, which is diffi-
cult to determine in excised tissue sections because of the
collapse and oblique sectioning of the majority of vessels
(own unpublished work).
We describe the vascular structure of a large series of
cutaneous melanomas in terms ofL,, S, and V, derived from
three independent morphometric measurements. The prog-
nostic value of tumour vascularity is assessed both
independently and in relation to other clinical and histo-
logical features.
Patients and methods
The study was based on the computerised melanoma registry
at Frenchay Hospital (Briggs, 1985). This registry includes
details of more than 2,500 patients treated since 1967. All
living patients are followed up and only 25 cases are per-
manently lost. One hundred and seven cases were selected on
the basis of lesion thickness within the range 0.85-1.25 mm
and a follow-up period of 5 years or greater. No cases of
malignant lentigo were included.
Serial five micron thick sections were cut from each of the
corresponding paraffin embedded tissue blocks and stained
with Haematoxylin and Eosin (H&E) for general histological
evaluation or the lectin Ulex europaeus type I (UAE-I) con-
jugated with alkaline phosphatase for visualisation of
endothelial cells (Holthofer et al., 1982).
The prognostic information was not known to the observer
at the time of morphometric measurement.
Vascular morphometry
The UAE-I stained slides were examined by light microscopy
at a magnification of x 200. Three anatomically distinct
areas of each section were identified for the measurement of
vascular parameters as described by Srivastava et al. (1986):
in the margin of normal papillary dermis adjacent to the
tumour, within the tumour itself and at the junction between
the tumour and underlying tissue.
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sets of measurements. Volume density (V,) was derived by
Chalkley's method (Chalkley, 1943) from area fraction esti-
mates made by point counting. Weibel's technique (1963) was
used to estimate vascular surface density (S,) by the mean
linear intercept method. Vascular length density (L,) was
derived from the mean number of vessel segments observed
per microscope field (Underwood, 1970), and the standard
deviation of these measurements used as an index of vascular
heterogeneity (H,). The special eyepiece graticules required
for point counting and line intersection counting were
obtained from Graticules Ltd, Tonbridge, UK (ref. G52 and
GW1).
The relationships used to derive the vascular parameters
are summarised in Table I. Between 48 and 80 fields were
examined for each region of interest to achieve a relative
standard error of approximately 10% for the estimation of S,
and V,. The number ofmicroscope fields necessary to achieve
a predetermined level of measurement uncertainty was esti-
mated prior to the study using a set of computer drawn test
objects of known circumference and area.
Results
Tumour vascularity
Vascular measurements were successfully completed in a high
proportion of the cases (74 normal dermis, 90 tumour and
100 tumour base), the most common reason for failure being
the exclusion of fragmented or partly missing tissue sections.
In all of but two of the tissue sections UEA-I stained the
a-ninthAlin oifl id-ntifinhhJ vpczlq with vnrinhla tnininia of UIMUtJLl>;ll VI1 Ill lu;ltlllUl VC;bbU1b, WIltl VallauIC; bLiZI111116 VI
keratin and the epithelial cells associated with hair follicles
and sweat glands. Care was taken to avoid the latter areas
when morphometric measurements were being made. Examples
of the vascular patterns exhibited by the melanomas are
shown in Figures 1 and 2. Two distinct patterns were seen in b
tumour (Figure 1); the vasculature appeared either to be
evenly distributed among the tumour cells or was confined to
the outer region of tumour cell 'nests' of up to 400ym
diameter. At the tumour base a higher proportion of large
calibre vessels was commonly found in the, more vascular
lesions (Figure 2a), however some lesions were associated
with a relatively sparse vasculature in this region (Figure 2b).
The range of values obtained for each of the vascular
parameters derived is summarised in Figure 3. A broad
distribution of vascularity in the tumour and particularly at
the tumour base can be seen relative to that of the adjacent
normal dermis. The relatively sparse vascularity found within
a proportion of lesions is seen in Figure 3c. In terms of
vascular heterogeneity the normal dermis and tumour base
were found to be broadly similar with a trend towards
greater heterogeneity within the tumour itself. Overall,
heterogeneity within tumour was comparable to that between
lesions, but at the tumour base greater variation was found
between tumours than within individuals.
The wide range of vascularity found at the tumour base
compared to normal dermis is illustrated in Figure 4. In the
Table I Vascular parameters derived from morphometric
measurements
Parameter Derivation No. offields
Length density 2 I n/N 20
L, (mm mm-3)
Surface density 2 Z n/NI 60-80
S, (mm2 mm-3)
Volume density In/N x 100 48
Vv (%)
Heterogeneity [I n2_ ( n)2IN I 100 20
H, (%) L N- I x L, Figure I Vasculature associated with primary cutaneous mela-
n = number of 'hits' scored by the respective morphometric noma, visualised by endothelial staining using Ulex europaeus
method. I= 72 jim, the length of test line used for mean linear type I lectin showing; a, vessels evenly distributed within tumour
intercept estimation. and b, vessels confined to the boundary of tumour cell 'nests'.104 P. CARNOCHAN et al.
Figure 2 Vasculature in the junctional region between tumour and underlying dermis showing; a, dense vascularity including many
large calibre vessels and b, a tumour with relative sparse vascularity in this region.
normal papillary dermis where vessel calibre is relatively
uniform the slope ofS, against L, gives a diameter of 7.8 gLm.
This value is within the overall range of 5-10 ,m reported
for the papillary loops of human skin (Braverman, 1989).
The small intercept of the regression line with the ordinate
may be explained by the bias introduced in defining the edge
of endothelial staining. It may be inferred that the vessels at
the tumour base may be of higher or lower 'average' calibre
by comparison with the regression line shown.
The relative vascularity of adjacent regions within individ-
ual sections is shown in Figure 5. In all cases, vascular
surface density at the tumour base was greater or equal to
that within tumour, and in general was greater than that of
adjacent normal dermis. In contrast, the vascular surface
density within tumour was either higher or lower than that of
adjacent dermis.
Correlation ofvascular parameters with clinical and
histologicalfeatures
The extent of tumour base vascularity in terms of S, is
summarised in relation to those clinical and histological
parameters studied in Table III. No explanation could be
found in terms of these features for the highly variable degree
of vascularity observed.
Of the 107 patients studied 86 remained disease free with a
minimum follow-up period of 5 years. Twenty-one patients
recurred (Table II). The only clinical feature commonly
associated with the recurrence group was the patient's sex.
Recurrent disease developed in 9/20 male patients compared
with 12/87 females (X2 test, P<0.005). Using stepwise dis-
criminant analysis, no relationship was found between
tumour recurrence and the patient's age, lesion thickness,
anatomical site, level of invasion (Clark), degree of lympho-
cytic infiltration, density of tumour cell mitoses or histo-
logical evidence of regression. That tumour vascularity was
not related to the likelihood of recurrence is seen in Figure 6.
These data are summarised in Table IV along with the
previously reported findings of Srivastava et al. (1988). Con-
sidering the recurrence group alone vascularity was found
not to be related to the type of recurrence, disease free
interval or duration of patient survival.
Discussion
The development of a vascular supply is essential for the
growth of all solid tumours beyond a size of approximately
1 mm (Folkman, 1985). Vascular access is also an important
prerequisite for the metastatic dissemination of tumour cells.VASCULARITY OF CUTANEOUS MELANOMA 105
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Figure 4 The length and surface density of vessels at the tumour
base in relation to adjacent dermis. 0 - dermis (n = 74); 0 -
tumour base (n = 100). Regression line fitted to dermis data only.
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Figure 3 The distribution of vascularity in cutaneous melanoma
and adjacent dermis. _ dermis (n
= 74); tumour
(n = 90); 1 - tumour base (n = 100).
This study documents the extent of vasculature associated
with cutaneous malignant melanomas of a size consistent
with an early stage of this vascular response.
Two potential sources of error must be acknowledged in
our quantitative histological method. Firstly it has been
assumed that all the vessels identified were functional. It is
likely that a proportion of the stained vessels were newly-
formed capillary 'sprouts', and therefore would not have
contributed to the tumour blood circulation in situ. Thus we
may have overestimated the effective vascular surface area.
Secondly, differences in the ultrastructure of vascular and
lymphatic endothelium may influence the relative efficiency of
tumour cell intravasation via these routes, and no attempt
was made to distiguish vascular from lymphatic vessels in our
study. The proportion of lymphatic capillaries in melanoma
Tumour/dermis Base/dermis Base/unmour
Figure 5 The relative vascularity of neighbouring regions in
primary cutaneous melanoma. 0 - tumour/normal dermis
(n = 68), A - tumour base/normal dermis (n = 74), 0 - tumour
base/tumour (n = 88).
has been shown to be small (Fallowfield & Cook 1990), and
therefore any structural differences were assumed to be of
negligible significance.
As a group the lesions studied exhibited a marked degree
of vascular heterogeneity, being apparently unrelated to other
clinical or histological features. A quantitatively similar dist-
ribution of melanoma vascularity was found by Srivastava et
al. (1986), who showed a significant correlation between vas-
cularity at the lesion base and tumour thickness in the range
0.2-9.0 mm. Our study covered a more restricted thickness
range (0.85-1.25 mm), suggesting that if this relationship
holds it is non-linear, and is consistent with the findings of a
further study by Srivastava et al. (1988) of lesions 0.8-3.7
mm in thickness in which no association between tumour
thickness and vascularity is apparent. One possibility is that
a breakpoint may occur at the clinically significant thickness
of 0.76mm, which may also explain the 'all or nothing'
observations of tumour blood flow using Doppler Ultra-
sound (Srivastava et al., 1986). A larger series of melanomas
covering an extended thickness range is needed to verify this.
In this study prognosis was not correlated with tumour
vascularity either independently or in combination with other
known prognostic variables. These findings do not confirm
those of a similar study by Srivastava et al. (1988), who
showed that tumour vascularity was on average lower in
their non-recurrence group. Possibly such a relationship may
have been obscured by inflammatory changes or tumour
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Table II Pattern of initial tumours recurrence
Type Incidence
Local 2
In-transit 2
Nodal 7
Systemic 6
Unspecified 4
Table III Tumour base vascularity in relation to clinical and his-
tological features
Mean S,
Variable Value Incidence (mm2mm-3) ±s.d.
Age (yrs)
<35 18 9.41 3.8
35-55 42 9.26 5.0
>55 40 9.53 4.1
Anatomical site
Chest/Abdomen 5 10.9 5.6
Back/Shoulder 13 11.6 5.2
Leg 58 9.41 4.4
Arm 15 8.83 3.5
Head/Neck 8 5.99 3.2
Type ofrecurrence
Local 2 12.0 -
In-transit 2 12.0 -
Nodal 7 11.8 6.3
Systemic 6 9.77 4.5
Lesion thickness (mm)
< 1.00 30 9.71 3.8
1.00-1.05 27 9.04 4.5
> 1.05 43 9.40 4.9
Lymphocytic infiltration
None 3 7.26 -
Minimal 14 8.12 3.3
Mild 25 8.75 5.3
Moderate 32 10.9 4.5
Maximal 26 9.12 4.0
Regression
None 29 7.73 3.6
Minimal 6 5.41 2.1
Mild 21 9.63 5.0
Moderate 20 11.2 4.2
Maximal 17 11.1 4.4
Frequency ofmitoses
Low (<1 per field) 41 10.2 4.1
High (., 1 per field) 54 8.74 4.8
regression at the time of surgery, but this is not supported by
our histological findings. Further, the incidence of spon-
taneous regression in primary cutaneous melanoma is com-
monly reported to be low (McGovern & Murad, 1985).
The variable extent of tumour vascularity, if expressed by
melanoma metastases also, could have implications for the
local distribution of pharmaceuticals intended for diagnosis
or therapy. If the surface area of the vascular bed is found to
be consistently higher at the tumour periphery compared
with adjacent tissue, then the detection of occult lesions on
this basis is worthy of investigation. Considering cytotoxic
drug delivery however, penetration beyond the peripheral
cells into the tumour may be expected to be highly non-
uniform for compounds unable to diffuse freely within the
interstitium. The presence of large calibre vessels within the
region of the tumour base suggests that favourable manipula-
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Figure 6 Clinical outcome in relation to tumour vascularity
within a, the tumour base region (0 - non-recurrence, n = 77;O}
- recurrence, n = 20) and b, the tumour (0 - non-recurrence,
n1= 70; * - recurrence, n= 17).
Table IV Tumour vascularity and prognosis
Diseasefree Recurrence
Parameter ±+s.d. (no. of cases)
Tumour Sv(mm2 mm-3) 5.04 4.66
±2.8(n=70) ±3.0(n=17)
Vv(%) 2.45 2.36
+±2.0(n=70) +±2.0(n=17)
Tumourbase Sv(mm2mm-3) 9.18 10.2
±4.5(n=77) ±4.5(n=20)
Vv(%) 5.76 6.89
+±4.5(n= 77) +±5.0(n=20)
Vv (%)a 1.57 4.60
1.3(n=10) ±3.3(n=10)
1Data from Srivastava et al., 1988.
tion of drug delivery using intravascular microsphere block-
age may be feasible.
Our findings suggest that vascular morphometry as applied
to cutaneous melanoma is not helpful prognostically within
the range of tumour thickness chosen. In this respect, the
assessment of other features of the tumour vasculature may
provide a useful complement to simple morphometry.
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